8-K//Current report
TETRAGENEX PHARMACEUTICALS, INC. 8-K
Accession 0001096906-11-000089
CIK 0001362659operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:29 AM ET
Size
456.9 KB
Accession
0001096906-11-000089
Documents
- 8-Kttrx8k20110120.htmPrimary
TETRAGENEX PHARMACEUTICALS, INC. FORM 8-K JANUARY 20, 2011
- EX-2.Ittrx8k20110120ex2-i.htm
SECOND AMENDED PREPACKAGED PLAN OF REORGANIZATION OF TETRAGENEX PHARMACEUTICALS, INC.
- EX-2.Ittrx8k20110120ex2-i.pdf
SECOND AMENDED PREPACKAGED PLAN OF REORGANIZATION OF TETRAGENEX PHARMACEUTICALS, INC. (PDF REFERENCE)
- EX-2.IIttrx8k20110120ex2-ii.htm
ORDER FROM THE UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK DATED JANUARY 6, 2011
- EX-2.IIttrx8k20110120ex2-ii.pdf
ORDER FROM THE UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK DATED JANUARY 6, 2011 (PDF REFERENCE)
- EX-3.Ittrx8k20110120ex3-i.htm
RESTATED CERTIFICATE OF INCORPORATION
- EX-3.IIttrx8k20110120ex3-ii.htm
RESTATED BYLAWS
Issuer
TETRAGENEX PHARMACEUTICALS, INC.
CIK 0001362659
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001362659
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 8:29 AM ET
- Size
- 456.9 KB